| # | Drug | Count |
|---|---|---|
| 0 | GEMCITABINE HYDROCHLORIDE | 130 |
| 1 | PACLITAXEL | 111 |
| 2 | GEMCITABINE | 83 |
| 3 | DURVALUMAB | 75 |
| 4 | ACETAMINOPHEN | 43 |
| 5 | TACROLIMUS | 38 |
| 6 | DEXAMETHASONE | 36 |
| 7 | DEXAMETHASONE 1.5 MG | 36 |
| 8 | TREMELIMUMAB | 36 |
| 9 | FLUOROURACIL | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VARDENAFIL | 10 | 0.0168 |
| 1 | TREMELIMUMAB | 36 | 0.0081 |
| 2 | DURVALUMAB | 75 | 0.0035 |
| 3 | SENNOSIDES A AND B | 4 | 0.0024 |
| 4 | GEMCITABINE HYDROCHLORIDE | 130 | 0.0024 |
| 5 | GLUTATHIONE | 3 | 0.0017 |
| 6 | URSOSIOL | 22 | 0.0011 |
| 7 | PACLITAXEL | 111 | 0.0011 |
| 8 | URSODIOL | 24 | 0.0011 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 4 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 75 | 0.0035 |
| 2 | Bile Acid [EPC] | 24 | 0.0010 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 41 | 0.0009 |
| 4 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 5 | Microtubule Inhibitor [EPC] | 119 | 0.0007 |
| 6 | Phenothiazine [EPC] | 16 | 0.0005 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 8 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 9 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |